about
Efficacy of Bacillus clausii spores in the prevention of recurrent respiratory infections in children: a pilot studyAcalculous Acute Cholecystitis in Previously Healthy Children: General Overview and Analysis of Pediatric Infectious CasesClinical and immunological data of nine patients with chronic mucocutaneous candidiasis diseaseEfficacy of Grintuss® pediatric syrup in treating cough in children: a randomized, multicenter, double blind, placebo-controlled clinical trial.Omalizumab in children.Local rhamnosoft, ceramides and L-isoleucine in atopic eczema: a randomized, placebo controlled trialStreptococcus pneumoniae colonisation in children and adolescents with asthma: impact of the heptavalent pneumococcal conjugate vaccine and evaluation of potential effect of thirteen-valent pneumococcal conjugate vaccine.Acute isolated sphenoid sinusitis in children.Acute Pustular Dermatosis, Following Topical Treatment With Pimecrolimus, in a Child Affected With Atopic and Contact Hand DermatitisNasal disease and asthma.Pathophysiology, favoring factors, and associated disorders in otorhinosinusology.Nasal cytology in children: recent advances.Adenoids in children: Advances in immunology, diagnosis, and surgery.Current recommendations and emerging options for the treatment of allergic rhinitis.Congenital vascular rings: a clinical challenge for the pediatrician.The discovery and development of omalizumab for the treatment of asthma.From IgE to clinical trials of allergic rhinitis.Emerging drugs for the treatment of perennial allergic rhinitis.Development of a peptide conjugate vaccine for inducing therapeutic anti-IgE antibodies.The Nose and the Lung: United Airway Disease?Cord and blood levels of newborn IgE: Correlation, role and influence of maternal IgE.Neuroendocrine cell hyperplasia of infancy: an unusual cause of hypoxemia in children.Clinical heterogeneity of dominant chronic mucocutaneous candidiasis disease: presenting as treatment-resistant candidiasis and chronic lung disease.Adenoids and clinical symptoms: Epidemiology of a cohort of 795 pediatric patients.Eosinophilic esophagitis after congenital diaphragmatic hernia.Outcome of oral provocation test in egg-sensitive children receiving semi-fat hard cheese Grana Padano PDO (protected designation of origin) containing, or not, lysozyme.An Update on Anti-IgE Therapy in Pediatric Respiratory Diseases.Omalizumab in Children with Severe Allergic Asthma: The Italian Real-Life Experience.New approaches for identifying and testing potential new anti-asthma agents.The role of upper airway pathology as a co-morbidity in severe asthma.A starch, glycyrretinic, zinc oxide and bisabolol based cream in the treatment of chronic mild-to-moderate atopic dermatitis in children: a three-center, assessor blinded trial.Current and future challenges in pediatric severe asthma.Valganciclovir treatment in a 6-month-old infant with asymptomatic congenital cytomegalovirus infection and late hearing loss.Detection of IL10-producing B cell (B10) in adenoids of atopic children with adenoidal hypertrophy.How to obtain informed consent for research.Difficult vs. Severe Asthma: Definition and Limits of Asthma Control in the Pediatric Population.Clinical use of Basophil Activation Test (BAT) in drug, food and hymenoptera venom allergiesInflammation of paranasal sinuses: the clinical pattern is age-dependentThe 10-day mark is a good way to diagnose not only acute rhinosinusitis but also adenoiditis, as confirmed by endoscopyRole of forced expiratory flow at 25–75% as an early marker of small airways impairment in subjects with allergic rhinitis
P50
Q24683036-8B835F99-DEF7-4CC5-8AE4-6D7FBC6FD2DEQ26774039-FF316664-AA10-4B9E-902E-D34810CD5214Q31059018-633E3B00-D1B0-4837-97E8-B215BB79413FQ33790915-597B2AE7-A03D-4866-A982-7533C4DA3944Q34604574-6A2A605F-B9BE-409C-B3BC-89C67D41831AQ34658901-F204810C-1784-49F9-A7D5-E59533E3B157Q35890971-06B2F374-7AE8-4312-832C-6686A3D97A3CQ36576147-1918927C-F5F4-4108-8C38-4DC9115746B4Q36652818-0CA64F09-E743-465F-9AF8-2277D1C447FCQ37950128-61D6F74D-9488-44C9-86D3-475646438453Q38023963-C5786293-201E-48BB-BEA3-4A031CA3AC6AQ38046241-2E800E70-81E3-4012-92A3-CB4C59F94D0CQ38188905-D66A33D3-1C3A-47E3-BB81-66010579BA8FQ38250070-79111E17-338D-48D6-B9D1-71B429E340DEQ38325433-E4F5D612-584F-45E3-952D-795F50DAD29AQ38483005-1F5E3E38-C31C-4043-B6FE-0798212333B3Q38584348-7CDAC59F-26D9-4514-9712-89F12B7CFFDDQ38687640-B04531E4-DED9-45B1-95D4-679E7232A95CQ39108259-86F545A2-D708-4662-BD30-96379DE928C8Q39186699-AD095471-1547-414D-9511-CEFFE84AEC36Q39452258-8F84654D-9960-4985-9AC1-86975376E591Q40540120-E3CEF98E-FCA9-4B4B-9867-C182DD453F31Q40844743-EB67E2D6-0BBC-4849-ABCE-141AE7CED5DBQ41205427-AB2E925E-12AA-48B8-9888-F06A5211C9DEQ42372247-E4F19484-A06A-4D5D-BF75-9B56DB53CEAFQ43345260-B13AC829-1713-47BC-B9ED-C408F1162E50Q47146658-1F95682A-2901-4202-9413-C467E1575E3CQ47275424-7D698DA7-DAED-477B-8A53-45F64AEE840DQ47873103-8E86820B-B3BD-4D9D-93B5-B0D46631DA7EQ48335095-51BAE33F-D33B-4FE1-9054-F7E559C45608Q48588370-CBF6D8CB-0EC5-4DD2-8EB9-C5EE228F603EQ50109566-08049B64-A650-4A5E-B21F-DB474AB7EBABQ50432413-A4B505B4-A663-4D69-B1F6-BCFD511CEA53Q55034716-1892ACC8-D213-4DDC-93EE-7C8270285F49Q55260408-16267F8D-7339-4C59-8EA3-6BF4E6A3DA54Q55409125-E16E0E10-D228-4E3C-A963-E6485FA3E314Q57297987-1F816E2E-3DE8-4733-93C0-3BC50C80783FQ57786325-62F3FA87-5DEC-4F9B-8EB8-4E55B3588E54Q57786361-BF12C81B-AC24-4456-A3A2-8789B3723BEDQ57786378-FC47BB1F-7EBA-4D14-9A79-0FF0D1A792C0
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Amelia Licari
@ast
Amelia Licari
@en
Amelia Licari
@es
Amelia Licari
@nl
type
label
Amelia Licari
@ast
Amelia Licari
@en
Amelia Licari
@es
Amelia Licari
@nl
prefLabel
Amelia Licari
@ast
Amelia Licari
@en
Amelia Licari
@es
Amelia Licari
@nl
P1053
J-5898-2016
P106
P1153
15057979700
P21
P31
P3829
P496
0000-0002-1773-6482